SOLENO THERAPEUTICS, INC.

Analyst Reco. Soleno Therapeutics, Inc.

Equities

SLNO

US8342033094

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
41.16 ^USD	-0.02%		-10.83%	+2.26%

May. 13	Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating	MT
May. 10	Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating	May. 13	MT
Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target	May. 10	MT
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing	Apr. 04	MT
Piper Sandler Starts Soleno Therapeutics With Overweight Rating, $93 Price Target	Feb. 05	MT
Stifel Starts Soleno Therapeutics With Buy Rating, $63 Price Target	Jan. 23	MT
Oppenheimer Lifts Price Target on Soleno Therapeutics to $47 From $44, Maintains Outperform Rating	Jan. 02	MT
Oppenheimer Adjusts Soleno Therapeutics Price Target to $44 From $39, Maintains Outperform Rating	Nov. 09	MT
Wall St slides as rate concerns keep Treasury yields near 16-year peak	23-09-26	RE
Cantor Fitzgerald Raises Price Target on Soleno Therapeutics to $35 From $19, Maintains Overweight Rating	23-09-26	MT
Oppenheimer Raises Soleno Therapeutics Price Target to $14 Form $8, Maintains Outperform Rating	23-09-15	MT
Cantor Fitzgerald Starts Soleno Therapeutics at Overweight With $19 Price Target	23-07-11	MT
Oppenheimer Adjusts Soleno Therapeutics PT to $8 From $2 to Better Reflect Recent Reverse Stock Split, Maintains Outperform Rating	22-11-15	MT
Oppenheimer Adjusts Soleno Therapeutics Price Target to $2 From $3, Maintains Outperform Rating	22-08-11	MT
Oppenheimer Adjusts Soleno Therapeutics' Price Target to $3 From $5, Maintains Outperform Rating	22-04-04	MT
History shows stocks can weather rate hike cycle	22-03-16	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer